CBPE announces investment into Access Infinity, a leading provider of Global Market Access Solutions
CBPE Capital (“CBPE”) is pleased to announce its investment in Access Infinity, a leading provider of market access, pricing, and evidence strategy solutions to the global pharmaceutical and biotech industries.
Founded in 2014, Access Infinity has established itself as a trusted partner for life sciences companies worldwide, providing a suite of software and consulting services that support clients throughout the drug development lifecycle. The company’s innovative software solutions (comprising Nuro, Access Hub and Evidence Hub) and expert consulting team help pharma clients navigate complex global market access challenges, optimise pricing strategies, and deliver value to patients across diverse healthcare systems.
CBPE’s investment will support Access Infinity as it accelerates its growth strategy, further develops its technology platform, and expands its international presence. The partnership will enable the company to continue investing in talent, innovation, and service offerings for its expanding customer base, which already includes 22 of the top 25 pharma companies.
CBPE has a strong track record of supporting ambitious, high-growth businesses in the healthcare and technology sectors. The investment in Access Infinity reflects CBPE’s confidence in the company’s leadership team and its commitment to supporting the next phase of growth.
We are delighted to partner with CBPE for the next stage of our journey. Their experience and support will be invaluable as we continue to grow our business, invest in our people, and deliver exceptional value to our clients.
We have been hugely impressed by Access Infinity’s expertise, innovation, and client-centric approach. We are excited to be working closely with the team to help realise their exciting plans for growth and continued leadership in the market access space.
Terms of the transaction were not disclosed.
CBPE’s investment in Access Infinity was led by Naveen Passi, with support from Rupert Parker, Maximilian O’Connell, Daniel Rossell and Jason Khaksar. Naveen Passi and Rupert Parker will join the Board post-completion.
CBPE was advised by Simmons & Simmons (legal), LEK (commercial), PwC (Tax & Structuring), Howden (Insurance), Anthesis (ESG), and Bourne Partners (M&A). Access Infinity was advised by Clearwater (M&A), Squire Patton Boggs (legal), KPMG (financial, tax), Boston Consulting Group (commercial), and Crosslake (technology).
